RLMD Trading Below Director's Recent Buy Price
October 28, 2019 at 10:46 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on October 21, Relmada Therapeutics Inc's Director, Maged Shenouda, invested $22,494.00 into 978 shares of RLMD, for a cost per share of $23.00..